ESC Premium Access

The cardioprotective mechanisms of SGLT2 inhibitors: What do cardiologists need to know?

Topic: Cardiovascular Pharmacotherapy
Organised by PACE-CME, supported with an educational grant provided by Boehringer-Ingelheim/Lilly

Presentation

About the speaker

Professor Nikolaus Marx

RWTH University Hospital Aachen, Aachen (Germany)
26 presentations
0 follower

4 more presentations in this session

Introduction

Speaker: Professor T. Luscher (London, GB)

Thumbnail

Heart & Kidney interactions: What are the challenges for prevention and protection?

Speaker: Professor C. Wanner (Wuerzburg, DE)

Thumbnail

Heart Failure: What are the practical consequences of current and ongoing SGLT2i outcome trials?

Speaker: Professor F. Zannad (Vandoeuvre-Les-Nancy, FR)

Thumbnail

Panel discussion

Speaker: Professor T. Luscher (London, GB)

Thumbnail

Access the full session

Expanding opportunities for SGLT2i in clinical cardiology

Speakers: Professor N. Marx, Professor T. Luscher, Professor C. Wanner, Professor F. Zannad, Professor T. Luscher
Thumbnail

About the event

Image

ESC CONGRESS 2019

31 August - 4 September 2019

Sessions Presentations

This platform is supported by

logo Novo Nordisk